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Abstract
Background: MicroRNA-21 (miR-21) is up-regulated in many cancers, including colorectal cancer (CRC).
Nevertheless, the function of miR-21 in CRC and the mechanism underlying that function is still unclear.
Methods: After analyzing the expression of miR-21 and Sec23A in CRC cell lines, we transfected the highest miR-21
expressing cell line, SW-480, with a plasmid containing an miR-21 inhibitor and the lowest miR-21 expressing cell
line, DLD-1, with a plasmid containing an miR-21 mimic and measured the effects on the expression of Sec23A and
on cell proliferation, migration, and invasion. We also evaluated the effect of knocking down Sec23A on miR-21
expression and its effects on cell proliferation, migration, and invasion. Finally, we assessed the effect of miR-21 in a
xenograft tumor model in mice. Tumor tissues from these mice were subjected to immunohistochemical staining
to detect the expression of Sec23A.
Results: Genetic deletion of miR-21 suppressed the proliferation, migration, and invasion of SW-480 cells, while
over-expression of miR-21 promoted proliferation, migration, and invasion of DLD-1 cells. Inhibition of miR-21
increased the expression of Sec23A protein in SW-480 cells while over-expression of miR-21 significantly suppressed
the expression of Sec23A protein and Sec23A mRNA in DLD-1 cells. Knockdown of Sec23A increased the expression
of miR-21 in SW480 and DLD-1 cells and their proliferation (DLD-1 only), migration, and invasion. Over-expression of
miR-21 promoted tumor growth in BALB/c nude mice and suppressed tumor expression of Sec23A.
Conclusion: These findings provide novel insight into the molecular functions of miR-21 in CRC, which may serve
as a potential interesting target.
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Background
Colorectal cancer (CRC) is the third most common cancer
and the fourth most common cause of cancer-related
death worldwide [1]. While chemotherapy is usually
effective in reducing tumor cell growth and counteracting
metastatic progression [2], it often loses efficacy, in
advanced CRC through development of chemoresistance
[3, 4], leading to disease recurrence and often patient
death. Thus, seeking for new therapeutic approaches are
needed to overcome this resistance, and targeted therapies
are believed to offer the greatest promise.
MicroRNAs (miRNAs) belong to a class of small
endogenous RNAs that influence many biological pro-
cesses through binding to the 3′- untranslated region of
target messenger RNA (mRNA), mediating either mRNA
degradation or translational repression [5]. Aberrant
miRNA expression is associated with many diseases, in-
cluding cancers [6–8]. Accumulating evidence indicates
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that miR-21 is involved in the pathogenesis and progres-
sion of cancer, including cell proliferation, migration, in-
vasion, metastasis, and apoptosis, by targeting PTEN,
PDCD4, TIMP3, and RHOB [9–12] or by playing im-
portant roles in signaling pathways such as, RAS/MEK/
ERK, PTEN/PI-3 K/AKT, and Wnt/β-catenin [13, 14].
Moreover, recent studies have shown that miR-21 is up-
regulated in CRC [15, 16] and that high levels of tumoral
miR-21 expression are associated with poor prognosis as
well as poor response to chemotherapy in patients with
CRC [17, 18].
Sec23A is one of two human Sec23 paralogs (Sec23A
and Sec23B). Sec23A is a GTPase-activating protein, an
integral component of the coat protein II complex that is
critical for protein trafficking between the endoplasmic
reticulum and Golgi apparatus [19, 20]. Emerging evidence
suggests that Sec23A is involved in anti-tumorigenesis. A
novel target for miR-375 and miR-200c, its expression is
reduced in prostate cancer cells and tissues [21]. Moreover,
as a direct target of miR-200s, Sec23A suppresses meta-
static colonization and migration in breast cancer by
mediating secretion of metastasis-suppressive proteins.
Furthermore, Sec23A levels are significantly lower in
clinical metastases relative to primary tumors [22].
Despite these findings of the biological roles of miR-21
and Sec23A, respectively in cancer, their relationship has
not been established in CRC. Therefore, we aimed to in-
vestigate the functions of miR-21 and Sec23A as well as
their relationship in CRC.
Methods
Cell lines and cell culture
CRC cell lines HT-29 (colorectal adenocarcinoma), SW-
480 (Dukes’ type B), and DLD-1 (Dukes’ type C)
representing different pathological stages of CRC were
purchased from the Institute of Biochemistry and Cell
Biology, Chinese Academy of Sciences (Shanghai, China).
All cells were cultured in RPMI-1640 medium (Gibco,
Carlsbad, CA) supplemented with 10 % fetal bovine serum
(FBS; Bioind, Beit-Haemek, Israel) in a humidified 37 °C
incubator supplemented with 5 % CO2.
Plasmid transfection
Cells were transfected with pGCMV/EGFP plasmids
containing hsa-miR-21 inhibitor or hsa-miR-21 mimic,
or empty vector (negative control [NC]), or with pGPU6
plasmids containing Sec23A shRNA (sh-Sec23A), or
control shRNA (sh-NC). The group which cells without
treatment defined MOCK. All constructs were synthe-
sized by GenePharma (Shanghai, China). SW-480 and
DLD-1 cells were grown to 80–90 % confluence and
then transfected. Transfection was carried out with
Lipofectamine 2000 (Invitrogen, Shanghai, China; DNA/
Lipofectamine 2000 ratio = 1/2.5) according to the
manufacturer’s instructions. Six hours after transfection,
the culture medium was replaced with fresh RPMI-1640
containing 10 % FBS. Stable transfectants were estab-
lished by incubating cells in complete RPMI-1640
medium with Blasticidin (12 mg/mL; Sigma, Shanghai,
China) for pGCMV/EGFP plasmids or G418 (500 mg/
mL; Sigma) for pGPU6 plasmids for 15 days. Clones
were verified by western blot and real-time quantitative
polymerase chain reaction (RT-PCR), and the successful
clones were pooled for the subsequent investigations.
Cell proliferation assay
For the cell proliferation assays, SW-480 cells stably
expressing miR-21 inhibitor, sh-Sec23A, or empty vector
or control shRNA were seeded at a density of 2 × 103
cells in 96-well plates and incubated for various periods
of time (0 to 5 days). DLD-1 cells stably expressing miR-
21 mimic, sh-Sec23A, or empty vector or control shRNA
were seeded at a density of 1 × 103 cells per well in 96-
well plates and incubated for the same periods of time.
Following incubation, Cell Counter Kit-8 (CCK-8; 10 μL)
reagent was added to each well and cells were incubated
at 37 °C for 1.5 h. Absorbance was measured at 450 nm
using an electroluminescence immunosorbent assay
reader as we described previously [23].
Cell migration assay
SW-480 and DLD-1 cells were washed twice with
serum-free RPMI-1640 medium and re-suspended in the
same medium. Cells were seeded (SW-480, 1 × 105;
DLD-1, 1.5 × 105) into the upper chambers of transwell
culture plates, each with an 8-μm pore membrane insert
(Corning, Shanghai, China). RPMI-1640 medium supple-
mented with 20 % FBS was placed in the lower chambers
as a chemoattractant. After incubation for 48 h, cells
that had penetrated through to the lower surface of the
membrane were fixed with 4 % paraformaldehyde for
20 min, stained with crystal violet for 20 min at ambient
temperature, photographed, and counted under a micro-
scope (Nikon, Tokyo, Japan) at × 100 magnification in
five randomly chosen fields.
Cell invasion assay
The cell invasion assay was similar to the migration
assay except that the transwell chambers were coated
with matrigel solution (40 μL per chamber; matrigel:-
serum-free medium ratio 1:10). SW-480, (2 × 105); or
DLD-1, (1.5 × 105) cells were seeded into the upper
chambers of the transwells and RPMI-1640 medium
with 20 % FBS (600 μL) was added to the lower cham-
bers. After 48 h incubation, the cells that had penetrated
the matrigel and moved to the lower surface of the
membrane were fixed with 4 % paraformaldehyde and
stained with crystal violet. Cells adhering to the upper
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surface of the membrane were removed with a cotton
swab. The cells attached to the lower surface were
counted and photographed under a microscope (Nikon)
at × 100 magnification in five randomly chosen fields.
Isolation of RNA and quantitative polymerase chain
reaction analysis
Forty-eight hours after transfection or after tumor dis-
section, total RNA was extracted from cultured cells or
ground tumor tissue using TRIzol (Invitrogen) accord-
ing to the manufacturer’s protocols. Total miR-21 or
Sec23A RNA (500 ng) was reverse transcribed to cDNA
with miRNA-specific RT primers (RiboBio, Guangzhou,
China) or random primers (TaKaRa, Dalian, China), re-
spectively. Gene expression was measured by PCR
using an Applied Biosystems 7500 Fast Sequence De-
tection System and SYBR Green PCR Kit (QIAGEN,
Shanghai, China) under the following conditions: de-
naturation at 95 °C for 5 min, followed by 40 cycles of
denaturation at 95 °C for 10 s and annealing and exten-
sion at 60 °C for 30 s. The relative miRNA and mRNA
expression levels were normalized to U6 and β-actin
expression, respectively.
Western blot analysis
Seventy-two hours after transfection or tumor dissec-
tion, cells were harvested and subjected to lysis in the
presence of a protease inhibitor cocktail and then to
centrifugation at 14,000 g for 15 min at 4 °C. The super-
natant fraction was collected and the protein concentra-
tion was measured by using a bicinchoninic acid protein
assay kit (Beyotime, Hangzhou, China). An aliquot of
40 μg of denatured protein from each sample was
treated with sodium dodecyl sulfate and applied to a
10 % polyacrylamide gel for electrophoretic separation,
then transferred onto a nitrocellulose membrane. After
blocking with 5 % nonfat milk for 2 h at ambient
temperature, membranes were incubated with primary
antibody (1:1000 dilution; Abcam, Shanghai, China) at
4 °C overnight and horseradish peroxidase-conjugated
secondary antibody (1:1000 dilution, Abcam) for 1 h at
ambient temperature. The blots were then incubated
with enhanced chemiluminescence solution for 1 min.
The signals were detected and quantified by densitom-
etry using Quantity One software. GAPDH was used as
an endogenous control.
Tumor xenografts in mice
Fifteen male athymic BALB/c nude mice (4-week-old)
were obtained from the Shanghai Medical Experimental
Animal Care Commission (Shanghai, China). All animal
procedures and experimental protocols were approved
by Laboratory Animal Ethics Committee of Wenzhou
Medical University. Based on in vitro findings, mice
were randomized into 3 groups. The experiment was
performed only once.
To establish xenograft tumors, DLD-1 cells (8 × 106 in
200 μL of medium) stably expressing miR-21mimic were
injected subcutaneously into the dorsal flank of each
mouse. Other mice were injected with cells transfected
with empty vector as NC as negative control or cells
without treatment as MOCK. Each mouse’s tumor was
measured weekly, beginning on day 7 after the injection,
by a Vernier caliper along two perpendicular axes. The
volume of the tumor was calculated with the formula:
volume = (length × width2)/2. Twenty-one days after the
injection, the mice were killed and the tumors were dis-
sected for analyses.
Immunohistochemical analysis
Tumor tissues were subjected to immunohistochemical
analysis for Sec23A with a kit (Boster, Wuhan, China)
used according to manufacturer’s instructions. Briefly,
each tissue section was deparaffinized, rehydrated, and
rinsed with phosphate-buffered saline solution (PBS).
High- pressure antigen retrieval was carried out in
citrate buffer, which was then removed by rinsing with
PBS. The sections were incubated with 3 % H2O2 for
8 min and then with 5 % normal goat serum for 30 min.
The sections were then sequentially incubated with
specific primary antibody (anti-Sec23A, Abcam), bio-
tinylated goat anti-rabbit IgG, and avidin-biotin-
peroxidase complex and rinsed with PBS. The slides
were stained with 3,3-diaminobenzidine, counterstained
with hematoxylin, and photographed under a light
microscope (×200 magnification).
Statistical analyses
Data were analyzed with SPSS 17.0 software and are
expressed as mean ± standard deviation (SD). Statistical
significance of differences between groups was deter-
mined by analysis of variance (ANOVA) or two-tailed
Student t-test. A p-value <0.05 was considered statisti-
cally significant. All experiments were performed at least
three times.
Results
MiR-21 expression in CRC cells
Levels of miR-21 mRNA were significantly higher in
HT-29 (colorectal adenocarcinoma) and SW-480
(Dukes’ type B) cells than in DLD-1 (Dukes’ type C)
cells (p < 0.05, p < 0.001, respectively; Fig. 1a). The
expression of miR-21 was significantly suppressed in
SW-480 cells transfected with miR-21 inhibitor
compared with negative controls (p < 0.01; Fig. 1b). In
contrast, transfection of miR-21 mimic into DLD-1
cells significantly increased the expression of miR-21
compared with negative controls (p < 0.01; Fig. 1c).
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MiR-21 overexpression stimulates proliferation, migration,
and invasion of CRC cells
Inhibition of miR-21 expression in SW-480 cells
resulted in decreased proliferation, migration, and
invasion compared with controls (all panels, p < 0.01;
Fig. 2a-c). In contrast, cell proliferation, migration, and
invasion were markedly increased in miR-21 over-
expressing DLD-1 cells compared with the controls (all
panels, p < 0.01; Fig. 2d-f ).
MiR-21 inhibits expression of Sec23A in CRC cell lines
Inhibition of miR-21 expression significantly increased
the expression of Sec23A protein in SW-480 cells
compared with controls (p < 0.01; Fig. 3a). There was no
significant difference in expression of Sec23A mRNA
between the SW-480 cells transfected with miR-21 in-
hibitor and controls (Fig. 3b). In contrast, miR-21 over-
expression significantly suppressed the expression of
Sec23A protein and mRNA in DLD-1 cells compared
with controls (p < 0.01, p < 0.05, respectively; Fig. 3c-d).
Expression of Sec23A and miR-21 in CRC cells
Sec23A mRNA levels were lower in untreated HT-29
and SW-480 cells than in untreated DLD-1 cells (all
p < 0.01; Fig. 4a). Sec23A mRNA levels did not differ
significantly between HT-29 and SW-480 cells. The
expression of Sec23A protein and mRNA levels in
SW-480 or DLD-1 cells was significantly suppressed
by transfection with sh-Sec23A compared with cells
tranfected with sh-NC (all panels, p < 0.01; Fig. 4b-e).
On the other hand, transfection with sh-Sec23A
significantly increased the expression of miR-21 in
SW-480 or DLD-1 cells compared with cells trans-
fected with sh-NC (all p < 0.01; Fig. 4f-g).
Downregulation of Sec23A promotes the proliferation,
migration, and invasion of CRC cells
Although downregulation of Sec23A had no significant
effect on SW-480 cell proliferation, it did promote the
migration and invasion of these cells compared with
sh-NC transfectants (all p < 0.01; Fig. 5a-c). DLD-1
cells in which Sec23A expression was inhibited exhib-
ited significantly greater proliferation, migration, and
invasion (all p < 0.05–0.01) than cells transfected with
sh-NC (Fig. 5d-f ).
MiR-21 overexpression promotes tumor growth in BALB/c
nude mice
Mice inoculated with miR-21 over expressing DLD-1
cells exhibited much faster tumor growth than the con-
trol or mock treatment groups (p < 0.01, p < 0.05, Fig. 6a).
The weights of tumors dissected on day 21 from the
mice inoculated with miR-21 over expressing DLD-1
cells were greater than those of the tumors from the
control or mock group (p < 0.01; Fig. 6b-d). The expres-
sion of miR-21 was significantly higher in the tumors
from the mice inoculated with miR-21 over expressing
DLD-1 cells than in those from the control or mock
treatment groups (p < 0.05; Fig. 7a). On the other hand,
expression of Sec23A protein was significantly lower in
tumors from the mice inoculated with miR-21 over ex-
pressing DLD-1 cells than in the tumors from the con-
trol or mock treatment groups (p < 0.01; Fig. 7b). This




























































Fig. 1 miR-21 is overexpressed in CRC cell lines. a Expression of miR-21 in untreated HT-29, SW-480, and DLD-1 cell lines. b The expression of miR-21
in SW-480 cells after transfection with miR-21 inhibitor, negative control (NC) or cells without treatment (MOCK). c The expression of miR-21 in DLD-1
cells after transfection with miR-21 mimic, negative control (NC) or cells without treatment (MOCK). * p < 0.05, ** p < 0.01, *** p < 0.001
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Fig. 2 MiR-21 overexpression stimulates proliferation, migration, and invasion of CRC cells. a-c Inhibition of miR-21 in SW-480 by miR-21 inhibitor
reduced cell proliferation, migration, and invasion relative to negative control (NC) and mock-treated cells (MOCK). d-f Up-regulation of miR-21 in
DLD-1 by miR-21 mimic increased proliferation, migration, and invasion relative to negative control and mock-treated cells. In panels b, c, e, and
f, photos on the left are representative images of migrated (b, e) and invaded cells on matrigel membranes (c, f), while the graphs on the right
indicate quantification of cells. ** p < 0.01
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showing lower Sec23A expression in the tumors from
mice inoculated with miR-21 over expressing DLD-1
cells (Fig. 7c).
Discussion
Our findings suggest that miR-21 promoted prolifera-
tion, migration, and invasion of SW-480 and DLD-1
CRC cells in vitro by down regulating the expression of
Sec23A. Moreover, over-expression of miR-21 promoted
tumor growth in BALB/c nude mice.
MiRNAs, dysregulated in many types of cancer, play
important roles in tumorigenesis [24–26]. In light of pre-
vious studies indicating that miR-21 level is increased in
CRC tissues and CRC cell lines [27, 28], we determined
the effect of miR-21 on the tumorigentic activities of rep-
resentative CRC cells as well as its relationship with
Sec23A. The expression of miR-21 in SW-480 was higher
than that in DLD-1 cells. There is no satisfactory explan-
ation for this discrepancy because that DLD1 tends to be
more metastatic than SW480 cells. The different effects
b









































































































Fig. 3 MiR-21 inhibits expression of Sec23A in CRC cell lines. a Inhibition of miR-21 expression promoted the expression of Sec23A
protein in SW-480 cells relative to negative control (NC) and mock-treated cells (MOCK). b There was no significant difference in
expression of Sec23A mRNA in SW-480 cells relative to negative control and mock-treated cells. c-d Over-expression of miR-21 by
miR-21 mimic decreased the expression of Sec23A protein and mRNA in DLD-1 cells relative to negative control and mock-treated
cells. Protein expression in these cells was determined by densitometric analysis. * p < 0.05, ** p < 0.01
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on Sec23A protein and mRNA in SW-480 and DLD-1
cells were discovered in this study suggesting that the
effects are cell line specific. Also, this may be attributed to
indirect regulation of miR-21 and involvement of other
regulators of the process of protein formation. Our data
show that miR-21 was over expressed in HT-29 and SW-
480 human CRC cells and that this over expression sup-
pressed Sec23A expression in these cells. Up-regulation of
miR-21 promoted CRC cell proliferation, migration, and
invasion while down-regulation of miR-21 resulted in
decreased proliferation, migration, and invasion of these
cells. These findings are consistent with earlier reports
that miR-21 induced invasion and metastasis [29] and that
miR-21 over-expression enhanced CRC cell proliferation,
migration, and invasion while miR-21 down regulation
inhibited these cells’ proliferation, migration, and invasion
[30–32]. Moreover, our finding that miR-21 over-















































































































































































Fig. 4 Sec23A knockdown increases expression of miR-21 in CRC cell lines. a Expression of Sec23A mRNA in untreated HT-29, SW-480, and DLD-1 cell
lines. b-c Sec23A mRNA and protein expression was suppressed in Sec23A knockdown SW-480 cells. d-e Sec23A mRNA and protein expression was
suppressed in Sec23A knockdown DLD-1 cells. Protein expression in these cells was quantified by densitometric analysis. f-g MiR-21 expression was
increased in Sec23A knockdown SW-480 and DLD-1 cells. ** p < 0.01
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tumors in BALB/c nude mice is in line with a previous re-
port that over-expression of miR-21 in colon cancer cells
increased their tumorigenic potential in SCID mice [13].
In our study, downregulation of Sec23A stimulated the
migration and invasion of SW-480 and DLD-1 cells and
the proliferation of DLD-1, which is similar to the effects
of miR-21 over-expression. This is consistent with the find-
ing of Szczyrba et al. that inhibition of Sec23A in prostate
carcinoma cells stimulated their proliferation [21]. In con-
trast, Korpal et al. suggested that Sec23A knockdown in-
hibits migration but promotes metastatic colonization of
breast cancer cells [22]. These discoveries suggest that the
effect of Sec23A knockdown may be different in different
cell lines or stages of tumor. We also observed that knock-
ing down the Sec23A significantly increases the expression
of miR-21 in SW-480 and DLD-1 cells. This suggests a
novel mechanism by which miR-21 contributes to tumori-
genesis through downregulation of Sec23A. To identify the
regulatory relationship between miR-21 and Sec23A, po-
tential targets of miR-21 were analyzed by bioinformatics
software, commonly used as targetscan for microRNA. Un-
fortunately, analysis showed that there were no binding
sites between miR-21 and Sec23A. Thus, we couldn’t dem-
onstrate that Sec23A is the direct target of miR-21, as
verified by luciferase reporter assay [33, 34] of miR-21.
There is probably a across talk between miR-21 and












































   
   






























   
   








































































   
   
   
   
   









   
   




Fig. 5 Downregulation of Sec23A promotes the proliferation, migration, and invasion of CRC cells. a-c Sec23A knockdown increased migration, and
invasion of SW-480 cells relative to negative controls (sh-NC). d-f Sec23A knockdown increased proliferation, migration, and invasion of DLD-1 cells
relative to negative controls. In panels b, c, e, and f, photos on the left are representative images of migrated (b, e) and invaded cells on Matrigel
membranes (c, f) while the graphs on the right indicate quantification of cells. * p < 0.05, ** p < 0.01
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Fig. 6 Over-expression of miR-21 enhances DLD-1 tumor growth in BALB/c nude mice. a Mice inoculated with miR-21 over-expressing
DLD-1 cells grew larger tumors than mice inoculated with negative controls (NC) or mock-treated cells (MOCK). b Tumor-bearing mice
before dissection. c The dissected tumors. d Tumors dissected from mice inoculated with miR-21 over-expressing DLD-1 cells weighed
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Fig. 7 Greater expression of miR-21 in DLD-1 tumors is associated with lower levels of Sec23A protein expression. a Tumors from mice inoculated with
miR-21 over-expressing DLD-1 cells expressed higher levels of miR-21 than tumors from mice inoculated with negative controls (NC) or mock-treated cells
(MOCK). b Tumors from mice inoculated with miR-21 over-expressing DLD-1 cells expressed lower levels of Sec23A than tumors from mice inoculated with
negative controls or mock-treated cells. c The expression of Sec23A in tumor tissues was determined by immunohistochemical staining; representative
images are shown (original magnification, ×200). * p< 0.05, ** p< 0.01
Li et al. BMC Cancer  (2016) 16:605 Page 9 of 11
Sec23A but we cannot confirm for now how it works. The
relationship and molecular pathways between miR-21 and
Sec23A require further investigation. An experiment with
double knock-in of miR-21 and Sec23A will be conducted
in our future study to further demonstrate this. Also it
would be interesting to determine the survival rate in each
group in animal model and even to conduct clinical study
to determine the association of miR-21 expression with
clinic-pathological parameters in future study.
Conclusion
MiR-21 is overexpressed in CRC cell lines and promotes
proliferation, migration, and invasion in these cells in vitro
associated with downregulation of Sec23A expression.
Over-expression of miR-21 also promotes the growth of
DLD-1 CRC tumors in BALB/c nude mice in vivo. These
findings suggest that miR-21 might be a potential interest-
ing target in CRC and may have therapeutic implications
for patients with this disease.
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